Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Recruiting 19Unknown 13Active not recruiting 13Completed 10Terminated 5Not yet recruiting 3Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 430Neoplasms 284Carcinoma, Non-Small-Cell Lung 266Colorectal Neoplasms 228Lung Neoplasms 173Prostatic Neoplasms 171Carcinoma, Hepatocellular 156Stomach Neoplasms 129Leukemia, Myeloid, Acute 118Pancreatic Neoplasms 115Multiple Myeloma 105Recurrence 96Uterine Cervical Neoplasms 91Squamous Cell Carcinoma of Head and Neck 88Neoplasm Metastasis 87Rectal Neoplasms 85Ovarian Neoplasms 77Triple Negative Breast Neoplasms 75Small Cell Lung Carcinoma 72Head and Neck Neoplasms 68Brain Neoplasms 68Esophageal Neoplasms 64Glioblastoma 63Colonic Neoplasms 60Endometrial Neoplasms 58Melanoma 54Hematologic Neoplasms 53Motor Activity 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Nasopharyngeal Carcinoma 46

Interventions

alovudine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Metastatic Castration-resistant Prostate Cancer × Clear all
NCT07608718 2026-05-27

Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting
19 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT07609225 2026-05-27

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

University of Wisconsin, Madison

Phase EARLY_PHASE1 Not yet recruiting
15 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT07172126 2025-09-15

Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Not yet recruiting
291 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡